ETV6 and acute lymphoblastic leukemia: Moreover, RUNX1 may also act as a recombinase cofactor decisive for recurrent pathological deletions in ETV6-RUNX1 ALL by enhancing RAG binding at RUNX1 heptamer binding sites.